Novo Nordisk India partners with Emcure Pharma to launch Poviztra semaglutide injection 2.4 mg in India
Emcure Pharma becomes the first Indian company with exclusive rights to distribute and commercialise Poviztra®, semaglutide injection 2.4 mg, for ...
Read moreDetails